These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 8390548)
1. Comparison of monovalent and trivalent live attenuated influenza vaccines in young children. Gruber WC; Kirschner K; Tollefson S; Thompson J; Reed G; Edwards KM; Wright PF J Infect Dis; 1993 Jul; 168(1):53-60. PubMed ID: 8390548 [TBL] [Abstract][Full Text] [Related]
2. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine. Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202 [TBL] [Abstract][Full Text] [Related]
3. Immunization of institutionalized asthmatic children and patients with psychomotor retardation using live attenuated cold-adapted reassortment influenza A H1N1, H3N2 and B vaccines. Miyazaki C; Nakayama M; Tanaka Y; Kusuhara K; Okada K; Tokugawa K; Ueda K; Shibata R; Nishima S; Yamane N Vaccine; 1993; 11(8):853-8. PubMed ID: 8356846 [TBL] [Abstract][Full Text] [Related]
4. Protective efficacy in mice of monovalent and trivalent live attenuated influenza vaccines in the background of cold-adapted A/X-31 and B/Lee/40 donor strains. Jang YH; Lee EY; Byun YH; Jung EJ; Lee YJ; Lee YH; Lee KH; Lee J; Seong BL Vaccine; 2014 Jan; 32(5):535-43. PubMed ID: 24342248 [TBL] [Abstract][Full Text] [Related]
5. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children. Belshe RB; Mendelman PM; Treanor J; King J; Gruber WC; Piedra P; Bernstein DI; Hayden FG; Kotloff K; Zangwill K; Iacuzio D; Wolff M N Engl J Med; 1998 May; 338(20):1405-12. PubMed ID: 9580647 [TBL] [Abstract][Full Text] [Related]
6. Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected children. King JC; Fast PE; Zangwill KM; Weinberg GA; Wolff M; Yan L; Newman F; Belshe RB; Kovacs A; Deville JG; Jelonek M; Pediatr Infect Dis J; 2001 Dec; 20(12):1124-31. PubMed ID: 11740317 [TBL] [Abstract][Full Text] [Related]
7. Safety and immunogenicity of a live-attenuated influenza vaccine blended and filled at two manufacturing facilities. Nolan T; Lee MS; Cordova JM; Cho I; Walker RE; August MJ; Larson S; Coelingh KL; Mendelman PM Vaccine; 2003 Mar; 21(11-12):1224-31. PubMed ID: 12559802 [TBL] [Abstract][Full Text] [Related]
8. Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children. Zangwill KM; Droge J; Mendelman P; Marcy SM; Partridge S; Chiu CY; Jing J; Chang SJ; Cho I; Ward JI Pediatr Infect Dis J; 2001 Aug; 20(8):740-6. PubMed ID: 11734734 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of bivalent live attenuated influenza A vaccines in children 2 months to 3 years of age: safety, immunogenicity and dose-response. Gruber WC; Darden PM; Still JG; Lohr J; Reed G; Wright PF Vaccine; 1997; 15(12-13):1379-84. PubMed ID: 9302748 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of live attenuated influenza vaccines in children 6-18 months of age: safety, immunogenicity, and efficacy. National Institute of Allergy and Infectious Diseases, Vaccine and Treatment Evaluation Program and the Wyeth-Ayerst ca Influenza Vaccine Investigators Group. Gruber WC; Belshe RB; King JC; Treanor JJ; Piedra PA; Wright PF; Reed GW; Anderson E; Newman F J Infect Dis; 1996 Jun; 173(6):1313-9. PubMed ID: 8648202 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of low and high doses of trivalent live cold-adapted influenza vaccine administered intranasally as drops or spray to healthy children. King JC; Lagos R; Bernstein DI; Piedra PA; Kotloff K; Bryant M; Cho I; Belshe RB J Infect Dis; 1998 May; 177(5):1394-7. PubMed ID: 9593032 [TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer. Carr S; Allison KJ; Van De Velde LA; Zhang K; English EY; Iverson A; Daw NC; Howard SC; Navid F; Rodriguez-Galindo C; Yang J; Adderson EE; McCullers JA; Flynn PM J Infect Dis; 2011 Nov; 204(10):1475-82. PubMed ID: 21949042 [TBL] [Abstract][Full Text] [Related]